<p>The proposed <a href="https://med.stanford.edu/cvi">Stanford Cardiovascular Institute</a> (SCVI) Biorepository will curate and manage an expanded collection of human induced pluripotent stem cell (iPSC) lines and provide investigators with iPSC materials generated using standardized protocols, with the overall objective of promoting the continued adoption and development of iPSC technology in cardiovascular research. Human iPSCs have revolutionized disease modeling, drug screening, and therapeutic research. However, it is also recognized that the need for specialized technical expertise and the associated cost have largely prevented individual research laboratories from adopting iPSC models in their inquiries, particularly in studies requiring multiple cell lines. To address this bottleneck, the proposed Biorepository will maintain our existing collection of iPSC lines and further expand the collection of iPSCs by recruiting 1,000 healthy, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) donors of both sexes and diverse racial/ethnic backgrounds (African Americans, Asians, Hispanics, and Whites).</p>

NHLBI TOPMed: Stanford Cardiovascular Institute iPSC Biobank Study (SCVI)

Heart Diseases study with SNP/CNV Genotypes (NGS) data on dbGaP (1,249 participants)

NHLBI TOPMed: Stanford Cardiovascular Institute iPSC Biobank Study (SCVI)

Description

Applying For Access

Summary